Brief: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2022 Financial Results
08/03/2023 21:05
March 8 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR-END
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* TRACON PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE,
BASIC AND
DILUTED $0.31
Source text for Eikon: ID:nGNXbJtCgS
Further company coverage: TCON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants